Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Extension of the MELODY Registry, to assess longterm follow-up clinical results of Melody valve implantation after its commercialization in Europe / OUS
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| primary outcome | • composite endpoint of TPVI related follow-up events (i.e. death, reoperation, or reintervention >48h after TPVI) | from december 2006 up to December 2027 |
| Measure | Description | Time Frame |
|---|---|---|
| secondary measure | TPVI infective endocarditis (I.E.) according to modified Duke criteria n | from december 2006 up to December 2027 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients who underwent Melody valve implantation into the pulmonary position after its commercialization in Europe / OUS
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Johannes Nordmeyer, Prof | Contact | +49 (0) 7071 29-84751 | Johannes.Nordmeyer@med.uni-tuebingen.de |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Tübingen | Recruiting | Tübingen | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006330 | Heart Defects, Congenital |
| ID | Term |
|---|---|
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
| D000013 | Congenital Abnormalities |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |